Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer

被引：0
|
作者：
François Audenet
Adam M. Farkas
Harry Anastos
Matthew D. Galsky
Nina Bhardwaj
John P. Sfakianos
机构：
[1] Icahn School of Medicine at Mount Sinai,Department of Urology
[2] Icahn School of Medicine at Mount Sinai,Division of Hematology and Oncology, Department of Medicine, Tisch Cancer Institute
来源：
World Journal of Urology | 2018年 / 36卷
关键词：
BCG; Immune checkpoints; Immune phenotype; Non-muscle invasive bladder cancer; Peripheral blood mononuclear cells; Predictive factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1741 / 1748
页数：7
相关论文
共 50 条
  • [21] Immune Therapies in Non-Muscle Invasive Bladder Cancer
    Philip L. Ho
    Stephen B. Williams
    Ashish M. Kamat
    Current Treatment Options in Oncology, 2015, 16
  • [22] Immune Therapies in Non-Muscle Invasive Bladder Cancer
    Ho, Philip L.
    Williams, Stephen B.
    Kamat, Ashish M.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (02)
  • [23] Relevance of the mammalian target of rapamycin pathway in the prognosis of patients with high-risk non-muscle invasive bladder cancer
    Fahmy, Mona
    Mansure, Jose Joao
    Brimo, Fadi
    Yafi, Faysal A.
    Segal, Robert
    Althunayan, Abdulaziz
    Hicks, Jessica
    Meeker, Alan
    Netto, George
    Kassouf, Wassim
    HUMAN PATHOLOGY, 2013, 44 (09) : 1766 - 1772
  • [24] Immuno-oncological therapeutic options in high-risk non-muscle invasive bladder cancer
    Kramer, M. W.
    Gakis, G.
    UROLOGE, 2020, 59 (07): : 784 - 789
  • [25] URINARY EXTRACELLULAR VESICLE RNA BIOMARKERS FOR HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER
    Minami, Keita
    Osawa, Takahiro
    Murakami, Taku
    Harada, Hiroshi
    Harabayashi, Toru
    Takada, Norikata
    Kashiwagi, Akira
    Hirakawa, Kazushi
    Sato, Yasuyuki
    Matsumoto, Ryuji
    Kikuchi, Hiroshi
    Abe, Takashige
    Murai, Sachiyo
    Shinohara, Nobuo
    JOURNAL OF UROLOGY, 2020, 203 : E1008 - E1009
  • [26] Chromosomal Imbalance in the Progression of High-Risk Non-Muscle Invasive Bladder Cancer Editorial Comment
    Montie, James E.
    JOURNAL OF UROLOGY, 2010, 183 (03): : 938 - 939
  • [27] Non-muscle invasive bladder cancer risk stratification
    Isharwal, Sumit
    Konety, Badrinath
    INDIAN JOURNAL OF UROLOGY, 2015, 31 (04) : 289 - 296
  • [28] Circulating tumor cells detection has independent prognostic Lipact in high-risk non-muscle invasive bladder cancer
    Gazzaniga, Paola
    de Berardinis, Ettore
    Raimondi, Cristina
    Gradilone, Angela
    Busetto, Gian Maria
    De Falco, Elena
    Nicolazzo, Chiara
    Giovannone, Riccardo
    Gentile, Vincenzo
    Cortesi, Enrico
    Pantel, Klaus
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (08) : 1978 - 1982
  • [29] Progression of high-risk non-muscle invasive bladder cancer correlates with immune phenotypes and Fibroblast Activation Protein-α (FAP)
    Muilwijk, T.
    Baekelandt, L.
    Akand, M.
    Daelemans, S.
    Marien, K.
    Waumans, Y.
    Van Dam, P-J
    Van den Broeck, T.
    Van Cleynenbreugel, B.
    Van der Aa, F.
    Gevaert, T.
    Joniau, S.
    EUROPEAN UROLOGY, 2023, 83 : S612 - S612
  • [30] HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER: PROGNOSTIC FACTOR OF CIRCULATING TUMOUR CELLS
    De Berardinis, E.
    Busetto, G. M.
    Sciarra, A.
    Cristini, C.
    Minisola, F.
    Di Pierro, G.
    Petracca, A.
    Nicolazzo, C.
    Di Silverio, F.
    Gazzaniga, P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 292 - 292
12345